Ersilia is a nonprofit enterprise focused on democratizing machine learning for biomedical research in infectious and neglected tropical diseases. The company aims to provide the community with a set of computational tools related to global health drug discovery, with a goal of lowering the barrier to the development of new medicines through open-source drug discovery. Founded in 2020, Ersilia builds and deploys thousands of predictive models related to target profiling, drug repurposing, and safety, with a special emphasis on neglected tropical diseases. Operating in the Health Care industry, Ersilia is poised to make significant contributions to the field of biomedical research and drug development.
There is no investment information
No recent news or press coverage available for Ersilia.